Looking beyond the headlines.
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D001897:Boronic Acids / Q000191:economics / Q000627:therapeutic use*; D000069286:Bortezomib; D003362:Cost-Benefit Analysis; D006801:Humans; D007342:Insurance Benefits; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000191:economics / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib